2018 Synthetic Biology: Engineering, Evolution & Design (SEED)
SEED 2018 focused on advances in science, technology, applications, and related investments in the field of synthetic biology. This year's theme was "synthetic biology at the leading edge of massive DNA synthesis, editing, and decoding.”
Here, synthetic biology will be broadly defined as cellular and biochemical technologies for accelerating bioengineering that are enabled by radical advances in DNA writing and reading. The conference highlighted recent discoveries and new tools that are positioned at the leading edge of rapid, massive DNA synthesis and editing. In addition, presentations and discussions featured the use of synthetic biology to broadly enable biotechnology applications, including therapeutics, industrial chemicals and fuels, natural products, and agriculture.
- James Collins, Massachusetts Institute of Technology
- Jay Keasling, University of California, Berkeley
- Floyd E. Romesberg, The Scripps Research Institute
- Pamela Ronald, University of California, Davis
There were be ten topic sessions under three major tracks.
- Reverse Engineering of Biological Systems
- Forward Engineering of Biological Systems
- Biological Frontiers: Newly Explored Systems
- Automation Technologies for Synthetic Biology
- DNA Writing and Assembly
- Engineering Functional Genomes
- Biological Frontiers: Newly Enabled Applications
- Biology-Inspired Materials
- Industrial Biotechnology
- Human Health
ChEnected sat down with Evelyn Eggenstein, Arbors Biosciences, prior to this year's Synthetic Biology conference (SEED).
James J. Collins is the Termeer Professor of Medical Engineering & Science and Professor of Biological Engineering at MIT. His research group focuses on using network biology approaches to study antibiotic action, bacterial defense mechanisms, and the emergence of resistance. His patented technologies have been licensed by over 25 companies.Read more